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Abstract
Background: Campylobacter jejuni is a gastrointestinal pathogen of humans, but part of the normal
flora of poultry, and therefore grows well at the respective body temperatures of 37°C and 42°C.
Proteomic studies on temperature regulation in C. jejuni strain 81–176 revealed the upregulation at
37°C of Cj0596, a predicted periplasmic chaperone that is similar to proteins involved in outer
membrane protein folding and virulence in other bacteria.
Results: The cj0596 gene was highly conserved in 24 strains and species of Campylobacter, implying
the importance of this gene. To study the role that Cj0596 plays in C. jejuni pathogenesis, a mutant
derivative of strain 81–176 was constructed in which the cj0596 gene was precisely deleted. A
revertant of this mutant was isolated by restoring the gene to its original chromosomal location
using streptomycin counterselection. The cj0596 mutant strain demonstrated a slightly decreased
growth rate and lower final growth yield, yet was more motile and more invasive of human
intestinal epithelial cells than wild-type. In either single or mixed infections, the mutant was less able
to colonize mice than 81–176. The cj0596 mutant also expressed altered levels of several proteins.
Conclusion: Mutation of cj0596 has an effect on phenotypes related to C. jejuni pathogenesis,
probably due to its role in the proper folding of critical outer membrane proteins.
Background
Campylobacter jejuni is a curved, microaerophilic Gram-
negative bacterium that is an important human pathogen
[1,2]. The main reservoir of C. jejuni is the cecum of poul-
try, and humans can become infected through consump-
tion of undercooked chicken that is contaminated with
the bacterium [2]. In humans, the bacterium colonizes
both the small and large intestine resulting in fever, severe
abdominal pain, and diarrhea, with possible autoim-
mune sequelae of infection including Guillain-Barré syn-
drome and reactive arthritis [3].
Expression of proteins is an energetically costly activity.
Therefore, bacteria often express certain proteins only
under conditions where those proteins are needed for
growth, survival, or pathogenicity. Growth temperatures
cause differential expression of proteins in a number of
pathogenic bacteria including C. jejuni [4-13], although
the mechanisms of thermoregulation can be complex and
result from overlapping regulatory systems. In C. jejuni,
the RacRS two-component regulatory system is involved
in the regulation of some proteins, although the majority
of the targets have not been identified [14]. Because the
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body temperatures of humans and chickens differ (37°C
and 42°C, respectively), C. jejuni is likely to express differ-
ent proteins when colonizing chickens than when colo-
nizing humans. We used proteomics to determine which
C. jejuni proteins are more highly expressed at 37°C com-
pared to 42°C, because such upregulation might suggest
an importance of these proteins in colonization of
humans. One of the proteins identified was Cj0596,
which is annotated as playing a role in outer membrane
protein folding and stabilization.
Cj0596 was previously identified as an immunogenic
outer membrane protein and was named cell binding fac-
tor 2 (cbf2); it is also called PEB4 [15-19]. It was later sug-
gested that PEB4 is not surface exposed, but is
periplasmically located in association with the inner
membrane [16]. Cj0596 shows homology to SurA, a pep-
tidyl-prolyl cis-trans isomerase (PPIase) found in E. coli,
and other orthologs in numerous bacteria including Heli-
cobacter pylori, Bacilis subtilis, and Lactococcus lactis [20-22].
PPIases have been characterized as virulence factors in
Shigella flexneri, Salmonella enterica, Legionella pneumophila,
Chlamydia trachomatis,  Trypanosoma cruzi, and Neisseria
gonorrhoeae [23-28]. Asakura et al. [29] recently character-
ized a cj0596 mutant of C. jejuni strain NCTC 11168, find-
ing decreases in ability to adhere to INT407 cells and to
colonize mice, and an increase in biofilm formation.
However, this mutant was not complemented with a wild-
type copy of cj0596, allowing some question of whether
the observed phenotypes were specific for Cj0596.
In this study, we examine the effects of deletion of cj0596
in a different, highly invasive C. jejuni strain (81–176) on
phenotypes related to growth, protein expression, and
pathogenicity. Our results show that deletion of cj0596
alters several virulence-related phenotypes in vitro and
decreases the ability of the bacterium to colonize mice,
although the phenotypes of the 81–176 cj0596 mutant
differ significantly from those of an analogous mutant in
strain NCTC 11168.
Methods
Bacterial strains and routine culture conditions
Campylobacter jejuni strains derived from the parent 81–
176 [30,31] (Table 1) were routinely maintained with
minimal passage on blood agar plates (Remel; Lenexa,
KS) at 37°C in sealed culture boxes (Mitsubishi Gas
Chemical [MGC], New York, NY) containing a microaer-
obic atmosphere generated by Pack-Micro Aero (MGC).
Liquid cultures of C. jejuni were grown in Brucella broth
or Mueller-Hinton (MH) broth and cultured in microaer-
Table 1: Strains used in this study
Strain Reference or source
C. jejuni 81–176 [30]
C. jejuni 81–176cj0596 This study
C. jejuni 81–176cj0596+ This study
C. jejuni NCTC11168 [22]
C. jejuni 81116 [43]
C. jejuni HB95-29 [44]
C. jejuni INP44 [44]
C. jejuni INP59 [44]
C. coli D3088 [44]
C. jejuni RM1221 TIGR CMR [62]
C. jejuni subsp. doylei 269.97 TIGR CMR [62]
C. jejuni subsp. jejuni 260.94 TIGR CMR [62]
C. jejuni subsp. jejuni 84-25 TIGR CMR [62]
C. jejuni subsp. jejuni CF93-6 TIGR CMR [62]
C. jejuni subsp. jejuni CG8486 [45]
C. jejuni subsp. jejuni HB93-13 TIGR CMR [62]
C. coli RM2228 TIGR CMR [62]
C. concisus 13826 TIGR CMR [62]
C. curvus 525.92 TIGR CMR [62]
C. fetus subsp. fetus 82–40 TIGR CMR [62]
C. hominis ATCC BAA-381 TIGR CMR [62]
C. lari RM2100 TIGR CMR [62]
C. upsaliensis RM3195 TIGR CMR [62]
E. coli BL21(DE3)pLysS [32]
H. pylori 84–183 [50]BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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obic environments. When appropriate, strains were cul-
tured in the presence of chloramphenicol (30 μg/ml) or
streptomycin (30 μg/ml) to select for antibiotic resistance
markers.
Escherichia coli JM109 was used as the host strain for clon-
ing experiments and E. coli BL21(DE3)pLysS [32] was
used as the host strain for expression of the his-tagged
Cj0596 protein. E. coli strains were cultured in Luria-Ber-
tani (LB) broth or agar [33], supplemented with the fol-
lowing antibiotics as appropriate for selection of
plasmids: ampicillin, 50 μg/ml; chloramphenicol, 30 μg/
ml; streptomycin, 30 μg/ml.
Proteome analysis of C. jejuni strains
Proteomics experiments were performed on C. jejuni cells
grown at 37°C and 42°C as described [34]. Briefly, cells
were grown overnight at 37°C in Brucella broth, then
diluted the following morning into two aliquots of fresh
Brucella broth (OD600 = 0.1), which were grown at 37°C
and 42°C to mid-log phase (OD600 = 0.1). Chloramphen-
icol (187 μg/ml) was added to stop protein synthesis [35],
and the cells were harvested for proteome analysis as
described [34]. Proteomics experiments were performed
using Differential In-Gel Electrophoresis (DIGE) technol-
ogy from GE Biosystems (Piscataway, NJ), Whole-cell pro-
tein lysates from the 37°C- and 42°C-grown C. jejuni (25
μg each) were labelled individually with Cy3 and Cy5
dyes according to the protocol supplied by the manufac-
turer (GE Biosystems), then mixed in equal mass and sep-
arated using two-dimensional (2D) SDS-PAGE.
For comparison of WT, mutant and revertant proteomes
(see below), protein lysates (25 μg each) were labelled
with Cy2 (wild-type 81–176), Cy3 (mutant 81–
176cj0596), or Cy5 (revertant 81–176 cj0596+) dyes,
mixed in equal mass, and separated by 2D SDS-PAGE.
Following separation, gels were scanned on a Typhoon
fluorescent flatbed scanner (GE Biosystems), at the fol-
lowing wavelengths: Cy2, 488 nm excitation, 520 nm
emission, Cy3, 532 nm excitation, 580 nm emission; Cy5,
633 nm excitation, 670 nm emission. Images were ana-
lyzed with Decyder Differential In-Gel Analysis (DIA)
software (version 4.0, GE Biosystems) for identification of
proteins with higher or lower expression in different sam-
ples. The identities of proteins of interest were determined
using a matrix-assisted laser desorption ionization – time-
of-flight/time-of-flight (MALDI-ToF/ToF) spectrometer
(Applied Biosystems, Foster City, CA), using both tryptic
fingerprint data and fragmentation-based MS/MS.
Purification of Cj0596 protein and antibody production
To allow purification of the Cj0596 protein, a C-terminal
his6-tag was added to cj0596 lacking the N-terminal signal
sequence by inserting the gene into pET-20b(+). First, the
cj0596 gene without the signal sequence and stop codon
was amplified from C. jejuni strain 81–176 and Nde I and
Xho I sites were added using primers purprot-F and pur-
prot-R (Table 2). The resulting PCR product was cloned
into pCR II-TOPO, creating plasmid pKR016 (Table 3).
Using Nde I and Xho I, the cj0596 gene was excised from
pKR016 and pET-20b(+) was linearized. The cj0596 gene
was ligated into the linearized pET-20b(+) creating plas-
mid pKR017, which was used to transform E. coli strain
BL21(DE3)pLysS (Table 1). The plasmid-carrying strain
was grown overnight in LB broth at 37°C. The next morn-
ing the culture was diluted to OD600 ~ 0.1 and incubated
at 37°C until OD600 ~ 0.5. IPTG was added to the culture
to induce expression of the his6-tagged protein. After 2 h,
the cells were harvested by centrifugation, washed, and
the supernatant passed through a nickel column to further
purify the his6-tagged protein by standard methods [36].
The purified protein was sent to Cocalico Biologicals, Inc.
(Reamstown, PA) for production of anti-Cj0596 antibod-
ies. For use in the PPIase assay, the protein was refolded
using the Pro-Matrix Protein Refolding Kit (Pierce Bio-
technology, Inc.) and dialyzed against PBS.
To confirm the proteomics-implicated temperature regu-
lation of Cj0596, a western blot was performed on C.
jejuni cells grown at 37°C or 42°C using anti-Cj0596 anti-
body (1:1,000) as the primary antibody and HRP conju-
gated goat anti-rabbit IgG (1:50,000) as the secondary
antibody. A control western blot against Cj0355 (expres-
sion of which is unaffected by growth temperature (Fields
and Thompson, unpublished results; [37]) was performed
using anti-Cj0355 antibody (1:1,000) as the primary anti-
body and HRP conjugated goat anti-rabbit IgG (1:50,000)
as the secondary antibody. The blots were developed
using a DAB Substrate Kit (BD Biosciences). Densitometry
measurements were conducted using ImageJ software
[38].
Localization of the Cj0596 Protein
To determine the cellular location of Cj0596, C. jejuni
cells grown at 37°C were separated into cytoplasmic, peri-
plasmic, and inner membrane fractions [39], and outer
membrane fractions as described [37]. Western blots were
performed on C. jejuni cell fractions using anti-Cj0596
antibody (1:1,000) as the primary antibody, along with
control blots using anti-Cj0355 (cytoplasmic control),
anti-CetA (inner membrane control), and anti-MOMP
(outer membrane control) polyclonal sera (all at 1:1,000)
as the primary antibodies. HRP conjugated goat anti-rab-
bit IgG (1:50,000) was used as the secondary antibody for
all blots, which were then developed using a DAB Sub-
strate Kit (BD Biosciences).
PPIase Assay
The PPIase activity of Cj0596 was determined in a cou-
pled assay, which measures the ability of Cj0596 to con-BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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vert the cis isomer of the oligopeptide substrate N-Suc-Ala-
Ala-Pro-Phe-p-nitroanilide into the trans  form which is
cleavable by α-chymotrypsin [40-42]. Chymotrypsin
(0.63 μg/ml) and varying concentrations of Cj0596 were
combined in 50 mM Tris-HCl pH 7.8 and incubated at
4°C. The substrate (93.8 μg/ml) was added and the reac-
tion was monitored at 10°C by the increase in absorbance
at 390 nm (corresponding to the release of p-nitroani-
lide). The kobs value for each PPIase concentration was
found by plotting Ln [A390(∞)-A390(t)] vs. time (sec) and
determining the slope. The catalytic efficiency (kcat/Km) of
the PPIase activity was obtained by plotting kobs vs. [PPI-
ase] and determining the slope.
Analysis of cj0596 in additional Campylobacter strains
The DNA sequences of the cj0596 locus (gene designation
from strain NCTC 11168; the strain 81–176 designation is
CJJ81176_0624) were determined from the Campylobacter
strains listed in Table 1[22,30,43-45]. Primers cj0596-F1
and cj0596-R1 (Table 2) were designed based on the pub-
lished NCTC 11168 genome sequence and used in PCR
reactions with template genomic DNA prepared using a
MasterPure DNA purification kit (Epicentre, Madison,
WI) to amplify the region encompassing cj0596. Thermo-
cycler parameters were 35 cycles of: 94°C for 30 seconds,
51°C for 30 seconds, and 72°C for 4 minutes. PCR prod-
ucts were purified using QIAquick PCR purification kits
(Qiagen, Valencia, CA) and were then sequenced directly
(both strands), using an ABI 3730xl sequencer (Applied
Biosystems). VectorNTI (version 7, Invitrogen, Carlsbad,
CA) was used to analyze DNA sequences. The protein
sequences were analyzed for motifs using the ExPASy
Prosite server http://au.expasy.org/prosite/[46,47], and
potential signal peptides were evaluated using SignalP 3.0
http://www.cbs.dtu.dk/services/SignalP/[48].
Isolation of a C. jejuni cj0596 mutant
A  cj0596  mutant of C. jejuni strain 81–176 was con-
structed using a streptomycin counterselection system
similar to the heterologous H. pylori-C. jejuni method
described by Dailidiene et al. [49] in which an rpsL gene
from C. jejuni was used for counterselection in H. pylori, to
Table 2: Primers used in this study
Primer Sequence (5' → 3')†
purprot-F CATATGGCTACAGTAGCTACTGTT
purprot-R CTCGAGTTTATATTCCACTTT
cj0596-F1 TTTTAGCTTTACAGGTGTAACG
cj0596-R1 ATCCACTCCATCTTCTTCGC
cj0596-inv1 ACCGGTTTTTAATAAAATGTATATAA
cj0596-inv2 ACCGGTTATGCTAGCAAAGTGGAATATAAATAATGGG
cat-F1 ACCGGTAAAACAATTGGGAGGATAAATGATGCAATT
cat-R1 GCTAGCTTATTTATTCAGCAAGTCTT
rpsLHP-F1 ACCGGTAACGACTAAAGTTTTAACA
rpsLHP-R1 CAATTGTCTTCAATCTTATTAAAAGCT
cj0597RT-F GACACAGATACTCAAATGGGC
cj0597RT-R CCAAACACGCGGATCATA
16S-RT-F GGGTGCTAGTCATCTCAGTAATGC
16S-RT-R GGTAAGGTTCTTCGCGTATCTTCG
purprot-F CATATGGCTACAGTAGCTACTGTT
purprot-R CTCGAGTTTATATTCCACTTT
†Bold nucleotides indicate restriction sites introduced for cloning purposesBMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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decrease background gene conversion events. In the heter-
ologous rpsLHP system reported here, cj0596 was exactly
replaced by the rpsLHP (StrS) gene from H. pylori strain 84–
183 (Table 1; [50]) linked to a chloramphenicol acetyl-
transferase (cat) cassette (CmR). This strategy allows for
selection of a mutant (StrS/CmR) based on chloramphen-
icol resistance and then allows for selection of a revertant
strain (StrR/CmS) based on streptomycin resistance. First,
a PCR-amplified cj0596 gene was amplified using primers
cj0596-F1 and cj0596-R1 designed based on the published
C. jejuni NCTC 11168 genome sequence (Table 2) and the
resulting product was cloned into pCR II-TOPO creating
pKR001 (Table 3). The plasmid pKR001 was subjected to
inverse PCR (primers cj0596-inv1 and cj0596-inv2) to
remove the cj0596  gene and add restriction sites. The
inverse PCR product was self-ligated to form plasmid
pKR002. The cat cassette was amplified from pRY111 [51]
and Age I, Mfe I, and Nhe I sites were added using primers
cat-F1 and cat-R1. The resulting PCR product was cloned
into pCR II-TOPO to create plasmid pKR018. The rpsLHP
gene was amplified and Age I and Mfe I sites were added
using primers rpsLHP-F1 and rpsLHP-R1 and the PCR prod-
uct was cloned into pCR II-TOPO creating plasmid
pKR019. Age I and Nhe I were used to excise the cat cas-
sette from pKR018 and linearize pKR002. The cat cassette
was ligated into pKR002 creating plasmid pKR020. Using
Age I and Mfe I, the rpsLHP  gene was removed from
pKR019 and ligated with linearized pKR020, creating
plasmid pKR021, with the rpsLHP/cat construct oriented in
the same direction as the cj0596 and cj0597 genes. Care
was taken to ensure that this replacement would not pro-
duce polar effects by preserving the cj0597 ribosome bind-
ing site and by leaving only 23 bp between the stop codon
of cat and the start codon of cj0597. The mutagenized
cj0596 allele was introduced into a spontaneous StrepR
derivative of C. jejuni 81–176 by electroporation. Several
CmR/StrepS transformants were verified as cj0596 mutants
by PCR with primers cj0596-F1 and cj0596-R1 (Table 2)
and DNA sequencing (data not shown), a representative
of which was designated 81–176cj0596  (Table 1) and
used for further analysis.
Reversion of the cj0596 mutation
A revertant of C. jejuni 81–176cj0596  was isolated by
replacing the mutated cj0596 allele in 81–176cj0596 with
a wild-type cj0596 gene using streptomycin counterselec-
tion. C. jejuni strain 81–176cj0596+ was created by using
electroporation to introduce pKR001 into 81–176cj0596
cells, selecting for colonies on plates containing strepto-
mycin (30 μg/ml). Putative revertants were identified by
screening StrR colonies for sensitivity to chloramphenicol
(30 μg/ml) to ensure loss of the rpsLHP/cat cassette. Chro-
mosomal DNA was isolated from these transformants and
proper replacement of the rpsLHP/cat cassette with wild-
type cj0596 was confirmed by PCR using primers cj0596-
F1 and cj0596-R1 (Table 2) and by DNA sequencing of the
region.
Quantitative real-time reverse transcription PCR
cDNA was prepared from RNA samples of C. jejuni grown
81–176 and 81–176cj0596 using a GeneAmp RNA PCR
kit (Applied Biosystems). An ICycler IQ real-time PCR
detection system (Bio-Rad Laboratories, Hercules, CA)
was used to run qRT-PCR with IQ Sybr Green Super Mix,
Table 3: Plasmids used in this study
Plasmid Description Source
pET-20b(+) Cloning vector, AmpR Novagen
pCR II-TOPO Cloning vector, KanR AmpR Invitrogen
pKR001 cj0596 gene and flanking region in pCR II-TOPO This study
pKR002 Self-ligated inverse PCR product of pKR001 with cj0596 removed This study
pKR016 cj0596 gene lacking signal sequence and stop codon in pCR II-TOPO This study
pKR017 cj0596 gene lacking signal sequence and stop codon in pET-20b(+) This study
pKR018 cat cassette in pCR II-TOPO This study
pKR019 H. pylori 84–183 rpsL gene in pCR II-TOPO This study
pKR020 cat cassette in pKR002 This study
pKR021 rpsLHP/cat construct in pKR002 This studyBMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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and primers cj0597RT-F and cj0597RT-R (Table 2). Data
were analyzed using Bio-Rad ICycler data analysis soft-
ware. Control reactions used primers specific for 16S
rDNA (16S-RT-F and 16S-RT-R, Table 2), which allows
amplification of a non-regulated RNA [52]. Differences in
transcript levels among samples were calculated from
amplification profiles using the comparative threshold
cycle (ΔΔCT) method, as previously described [53].
Growth experiments
The growth rates of C. jejuni wild-type 81–176, mutant
81–176cj0596, and revertant 81–176cj0596+  were
assessed by growing cells overnight in MH broth, then
diluting the following morning in MH Broth to OD600 ~
0.06 (the cj0596 mutant was additionally inoculated at
OD600 ~ 0.2 due to poor correlation between OD600 and
CFU for this strain; see Results) and shaking at 37°C
under microaerobic conditions. Growth was monitored
by measuring OD600 and numbers of viable bacteria were
determined by plating serial dilutions of the bacterial sus-
pensions on MH agar and counting the resultant colonies.
Motility
The motility of C. jejuni 81–176, 81–176cj0596, and 81–
176cj0596+ was determined as previously described [54].
Briefly, cells were grown overnight in MH broth, then
diluted the following morning in MH broth to OD600 =
0.1. A pipet tip dipped into the suspension was used to
stab the center of a MH motility plate (0.4% agar). The
plates were incubated at 37°C and the diameter of the
motility zone was measured every 12 h.
Adherence/Invasion/Intracellular survival assay
A gentamicin protection assay [34,55] was used to assess
the ability of 81–176, 81–176cj0596, and 81–176cj0596+
to adhere to, invade, and survive within INT407 human
intestinal epithelial cells. Briefly, bacteria were grown in
biphasic [brain heart infusion (BHI)/1% yeast extract
(YE)] cultures at 37°C under microaerobic conditions for
~20 h. Bacteria were harvested, resuspended in phosphate
buffered saline (PBS), then added in triplicate to semi-
confluent INT407 cell monolayers (~1 × 105 cells/well) at
a multiplicity of infection (MOI) of ~40:1 (bacteria:epi-
thelial cells). The number of bacteria added was quanti-
fied by determination of CFU/mL. The cells were
incubated for 3 h at 37°C under microaerobic conditions
and were washed with Hanks' Balanced Salt Solution
(HBSS), lysed with Triton X-100 and the number of
adherent bacteria was quantified by viable counts. For
determination of invasion, cells were incubated for 3 h
with bacteria and then gentamicin was added to a final
concentration of 250 μg/ml to kill any extracellular bacte-
ria. After an additional 2 h of incubation, the cells were
washed, lysed with Triton X-100 and intracellular bacteria
were quantified by viable counts. The gentamicin and Tri-
ton X-100 MICs of the three strains were also determined.
For determination of intracellular survival, the cells were
incubated for 3 h with bacteria, 2 h with gentamicin, and
then the INT407 cells were washed and incubated for 4 h
in minimal essential media containing 3% fetal bovine
serum and gentamicin (10 μg/ml) as described by Can-
don et al. [56]. After the incubation period, cells were
washed and lysed with Triton-X 100 and the number of
bacteria that survived intracellularly was quantified by
viable counts.
Mouse Colonization Experiments
The in vivo relevance of Cj0596 was investigated by testing
the ability of 81–176, 81–176cj0596, and 81–176cj0596+
to colonize mice as described [34,57,58]. 10-week old
female BALB/c-ByJ mice were given 500 μl of 5% sodium
bicarbonate by oral gavage to neutralize stomach acid.
The mice were then given a dose of 1 × 109 CFU in 500 ml
of BHI/1% YE broth by oral gavage. Because there was an
observed discrepancy between OD600 and CFU for the
mutant (see Results), we first performed pilot experiments
correlating OD600 and CFU for all of the strains. After four
repetitions, we found the mutant OD600 that gave the
same number of CFU as for the WT and revertant strain,
and this is what we used for the mouse inocula. We also
verified that each mouse received equal CFU by plating
the inocula for viable counts at the time of inoculation.
Colonization was determined by viable counts of bacteria
in fecal pellets, which were enumerated on selective CVA
media [59] starting 7 days after the challenge and contin-
uing every 7 days thereafter until 35 days post-inocula-
tion.
In parallel, experiments were carried out to determine the
ability of cj0596 mutant bacteria to compete with wild-
type bacteria in colonization. For competition experi-
ments, wild-type and mutant bacteria were mixed in equal
amounts (5 × 108 CFU each) immediately prior to inocu-
lation. Colonization was determined by enumerating bac-
teria on selective media with or without chloramphenicol
(30 μg/ml). The number of bacteria counted on the plates
containing chloramphenicol (viable mutant bacteria) was
subtracted from the number of bacteria found on the
plates without chloramphenicol (total of mutant and
wild-type bacteria) to obtain the number of viable wild-
type bacteria. Control experiments showed that the plat-
ing efficiency of the Cj0596 mutant was equivalent on
media containing or lacking chloramphenicol. All verte-
brate animal experiments were conducted in accordance
with recommendations by the Office of Laboratory Ani-
mal Welfare, and were approved by the Medical College of
Georgia Institutional Animal Care and Use CommitteeBMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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(MCG IACUC; protocol 04-03-379B, approved 3/18/
2004).
Results
Expression of cj0596 is slightly higher at 37°C than at 42°C
In a search to identify C. jejuni genes with differential
response to steady-state growth temperature (37°C vs.
42°C), several proteins were identified that were more
highly expressed at 37°C than at 42°C. C. jejuni 81–176
was grown overnight at 37°C and then diluted into fresh
media. The two cultures were grown in parallel at 37°C
and 42°C to mid-log growth phase. Proteomics experi-
ments were then performed on cultures of C. jejuni 81–
176 grown at the two temperatures. One protein that was
upregulated at 37°C had the approximate pI and molecu-
lar mass of the predicted Cj0596 protein (Figure 1). This
protein was 1.8-fold more highly expressed at 37°C, a
result that was consistent in five different proteomics
experiments. The protein was excised from the polyacryla-
mide gel and subjected to MALDI-ToF/ToF mass spec-
trometry. This protein was identified with 100%
confidence as Cj0596 (data not shown).
In an attempt to confirm the proteomics results, we per-
formed western blots using anti-Cj0596 antibodies and C.
jejuni 81–176 grown at 37°C and 42°C. While only semi-
quantitative, in two separate experiments the western
blots showed a more modest 1.3–1.6-fold greater expres-
sion of Cj0596 at 37°C (data not shown). Therefore, we
conclude that while Cj0596 appears to be expressed at a
somewhat higher level at 37°C compared to 42°C, the
effect of growth temperature on Cj0596 expression is not
dramatic. Because proteins homologous to Cj0596 are
involved in virulence in other pathogenic bacteria, we
nevertheless characterized the role of this protein in C.
jejuni physiology and pathogenesis.
Similarity of cj0596 sequences among Campylobacter 
species
Because Campylobacter genomes are quite diverse [60,61],
we characterized the conservation of the cj0596 gene in
other Campylobacter strains. Using PCR primers designed
from the C. jejuni NCTC 11168 genomic sequence and
located in the cj0595  and  cj0597  genes (Figure 2), we
amplified a 2 kb segment encompassing the cj0596 locus
from five additional C. jejuni strains and one C. coli strain.
PCR products of the expected size were obtained from
each strain, and were subsequently sequenced (total of
4000 bp sequence analyzed for each strain). A search of 17
additional Campylobacter genome sequences (Table 1) was
also performed and showed that a cj0596 ortholog was
found in every strain. The sequences of these orthologs
were also included in the sequence comparison analysis.
The nucleotide sequences between pairs of C. jejuni strains
or C. coli D3088 were at least 98% identical. The corre-
sponding sequences from C. coli RM2228 and other
Campylobacter species were somewhat lower (84% to 60%
identical). The predicted Cj0596 protein was also highly
similar in all C. jejuni strains and C. coli D3088, with an
amino acid sequence identity of at least 99%. As with the
nucleotide sequences, the degree of identity of proteins
from C. coli RM2228 and other non-jejuni Campylobacter
strains was lower, with identities ranging from 87% to
45%. Together, these results indicate that cj0596 is highly
conserved in C. jejuni (16 strains), C. coli (two strains),
and one strain each of C. concisus, C. curvus, C. fetus, C.
hominis, C. lari, and C. upsaliensis. We focused on Cj0596
from C. jejuni strain 81–176 (the strain 81–176 designa-
tion is CJJ81176_0624) for our subsequent work.
Temperature-dependent changes in the expression level of  the Cj0596 protein Figure 1
Temperature-dependent changes in the expression 
level of the Cj0596 protein. Two-dimensional SDS-PAGE 
protein gel showing the expression of C. jejuni 81–176 pro-
teins at 37°C and 42°C. The Cj0596 protein identified using 
mass spectrometry is indicated by a box.
Construction of a cj0596 mutant in C. jejuni 81–176 Figure 2
Construction of a cj0596 mutant in C. jejuni 81–176. 
The location of the replacement of the cj0596 gene by the 
rpsLHP/cat construct is shown. Solid arrows represent PCR 
primers used to amplify the cj0596 region during mutant 
construction and verification, and for interstrain comparative 
DNA sequencing.BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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In silico analysis of Cj0596 protein features
In the NCTC 11168 genome, the predicted Cj0596 pro-
tein had a predicted molecular mass of 30.5 kDa and pI of
9.9 and was annotated as a major antigenic peptide
PEB4\cell binding factor 2, similar to peptidyl prolyl cis-
trans  isomerases found in a variety of organisms [62].
Because some peptidyl-prolyl cis-trans  isomerases are
located in the periplasm, the SignalP algorithm [48,63]
was used to analyze the 81–176 Cj0596 protein for the
presence of an N-terminal signal sequence. A signal
sequence with a probable cleavage site between amino
acids 21 and 22 of the preprotein (VNA↓AT) was pre-
dicted. Cj0596 was also analyzed for the presence of pro-
tein motifs [46] and was found to contain a PpiC-type
peptidyl-prolyl cis-trans isomerase motif located between
amino acids 131–228. Secondary structure predictions
showed no transmembrane segments in the mature pro-
tein, suggesting that Cj0596 is likely to be a periplasmic
protein.
Cj0596 is located in the periplasm of C. jejuni
The amino acid sequence of Cj0596 suggested that this
protein is located in the periplasm. To test this experimen-
tally, western blots were performed on cytoplasmic, inner
membrane, periplasmic, and outer membrane fractions of
C. jejuni 81–176 using anti-Cj0596, anti-Cj0355, anti-
CetA, and anti-MOMP antibodies (Figure 3). As expected,
anti-Cj0355 antibodies reacted with a ~25 kDa protein in
the cytoplasmic fraction, anti-CetA antibodies reacted
with a ~50 kDa protein in the inner membrane fraction,
and anti-MOMP antibodies reacted with a ~45 kDa pro-
tein in the outer membrane. Anti-Cj0596 antibodies
reacted with a ~30 kDa protein present primarily in the
periplasmic fraction.
Cj0596 has PPIase Activity
Cj0596 has one rotamase domain and is similar to E. coli
SurA, suggesting that it is a PPIase. The PPIase activity of
purified Cj0596 was determined using a coupled assay in
which the cleavage of the trans isomer of N-Suc-Ala-Ala-
Pro-Phe-p-nitroanilide by α-chymotrypsin results in the
release of p-nitroanilide, causing a colorimetric change
over time. Conversion of the cis to the trans isomers of the
substrate occurs spontaneously in solution, allowing chy-
motrypsin cleavage (Figure 4, squares). However, addi-
tion of Cj0596 accelerates this cis-trans  conversion,
indicative of PPIase activity (Figure 4, diamonds). By
using varying concentrations of purified Cj0596 (data not
shown) and plotting calculated kobs vs. [PPIase], the PPI-
ase activity (kcat/km) was calculated to be 22.3 mM-1sec-1,
an activity consistent with values published for other PPI-
ases [64-66].
Creation of a non-polar cj0596 mutation
To test the role of Cj0596 in C. jejuni physiology or patho-
genesis, we created a non-polar cj0596 mutant. To facili-
tate mutant construction, we developed a modified
streptomycin counter selection system based on a similar
strategy used in H. pylori [49]. The rpslHP/cat  cassette
(Methods) was used to precisely replace cj0596, maintain-
ing the ribosome binding site of the downstream cj0597
gene. Together with the lack of a transcriptional termina-
tor on the rpslHP/cat cassette, this construct is expected to
yield a non-polar mutation. The resulting mutant strain
was designated 81–176cj0596. To confirm that mutation
Localization of Cj0596 Figure 3
Localization of Cj0596. Western blots of cell fractions 
using Cj0355 as a cytoplasmic control, CetA as an inner 
membrane control, and MOMP as an outer membrane con-
trol show that Cj0596 is located in the periplasm of C. jejuni.
PPIase activity of Cj0596 Figure 4
PPIase activity of Cj0596. Enzymatic activity of Cj0596 
assayed by cleavage of N-Suc-Ala-Ala-Pro-Phe-p-nitroanilide 
in a chymotrypsin-coupled assay, in which cleavage of the 
trans isomer of the substrate by chymotrypsin is accelerated 
by PPIase activity. A representative plot of Absorbance vs. 
time using purified Cj0596 protein (red diamonds) and nega-
tive control (black squares) is shown.BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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of the cj0596 gene did not alter the expression of the puta-
tive co-transcribed cj0597 gene, quantitative real-time RT-
PCR was performed on RNA samples harvested from 81–
176 and 81–176cj0596. These studies confirmed that
mRNA levels downstream of the mutation in 81–
176cj0596 were equivalent to those in 81–176, and that
the mutation was non-polar (data not shown). However,
to ensure that any phenotypes of the cj0596 mutant were
specific for cj0596, we subsequently isolated a reversion of
the mutation by replacing the rpslHP/cat cassette with a
wild-type cj0596 gene. Analogous to the counterselection
system of Dailidiene et al. [49], use of the H. pylori rpsL
gene decreased background gene conversion events and
facilitated the recovery of cells in which the mutagenized
cj0596 allele was replaced with the wild-type cj0596 gene.
This process was extremely efficient, as ~70% of the recov-
ered streptomycin-resistant colonies contained the
desired reversions of the cj0596 mutation.
Mutation of cj0596 causes a moderate growth defect of C. 
jejuni in MH broth
The role of Cj0596 in Campylobacter growth was studied
by comparing the growth rates of C. jejuni 81–176, 81–
176cj0596, and 81–176cj0596+ in MH broth (Figure 5).
When inoculated at OD600 ~ 0.06 and growth rate was
measured by OD600  (Figure 5A), the mutant initially
appeared to have a significant growth defect illustrated
both by a slower increase in OD600 and a lower maximum
OD600. However, we also found that a similar starting
OD600 resulted in a significantly lower starting CFU for the
mutant, indicating that the OD600  did not accurately
reflect the number of cj0596 mutant CFU. We then grew
the mutant under two starting conditions: one had the
same starting OD600 as the wild-type and revertant (OD600
~ 0.06) and the other had approximately the same starting
CFU (OD600 ~ 0.2) as the wild-type and the revertant. The
mutant inoculated at OD600 ~ 0.2 showed a faster initial
increase in OD600, but reached a similar maximum OD600
as the mutant inoculated at OD600 ~ 0.06. However, when
growth rate was monitored by plating for viable counts
(Figure 5B), the mutant had an initial growth rate more
similar to that of wild-type, although both mutant cul-
tures yielded final viable counts lower than wild-type.
Wild-type growth characteristics were restored in the
revertant strain. Together, these data suggest that muta-
tion of cj0596 resulted in a moderate growth defect, espe-
cially later in the growth curve, and that the cj0596 mutant
had apparent changes in cell characteristics such that the
OD600 had poor concordance with CFU measurements.
Deletion of cj0596 increases the motility of C. jejuni
Because motility plays an important role in invasion of
host intestinal cells and is required for animal coloniza-
tion, the motility of C. jejuni 81–176, 81–176cj0596, and
81–176cj0596+ was compared at 37°C (Figure 6). The
average diameter of the zone of motility for the wild-type
was 39.3 mm ± 3.7 at 48 h. The mutant was significantly
more motile with a zone diameter of 66.0 mm ± 2.4 (p <
0.0001). The revertant returned to wild-type motility lev-
els with a zone diameter of 42.5 mm ± 3.0. A similar
increase in motility was seen when the assay was per-
formed at 42°C (data not shown). Thus, Cj0596 is
involved in the expression of motility.
Deletion of cj0596 increases the ability of C. jejuni to 
invade INT407 cells, but does not affect adherence or 
intracellular survival
The possibility that Cj0596 plays a role in interaction with
host cells was studied by comparing the adherence and
invasion abilities of C. jejuni 81–176, 81–176cj0596, and
81–176cj0596+ in an in vitro assay using INT407 intestinal
epithelial cells (Figure 7). The mean percentages of the
inoculum that adhered were 8.5 (± 1.4), 7.2 (± 0.7), and
4.7 (± 1.2) for the wild-type, mutant, and revertant,
respectively, demonstrating that deletion of Cj0596 does
Growth of C. jejuni strains at 37°C in MH broth Figure 5
Growth of C. jejuni strains at 37°C in MH broth. 
Strains 81–176 (black diamonds), 81–176cj0596 ("low" inocu-
lum, red triangles) and 81–176cj0596+ (blue squares) were 
inoculated at an OD600 of ~0.06 and growth was monitored 
by OD600 (A) as well as CFU mL-1 (B). Additionally, 81–
176cj0596 ("high" inoculum, orange squares) was inoculated 
at an OD600 of ~0.2.BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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not significantly affect the ability of C. jejuni to adhere to
INT407 cells (p > 0.05; Figure 7A). In contrast, mutation
of cj0596 had a significant effect on the invasion ability of
C. jejuni. While the percentages of the wild-type and rever-
tant inocula invading INT407 cells were 0.041 (± 0.007)
and 0.027 (± 0.005), respectively, the cj0596  mutant
showed a nearly 20-fold increase in invasion (0.76 ± 0.11,
p < 0.001; Figure 7B). The gentamicin and Triton X-100
sensitivities of the three strains were tested to ensure that
the invasion results were not due to altered killing of a
strain, and no significant difference was found for either
compound.
Compared to the number of bacteria that invaded the
INT407 cells, the percentages of wild-type, mutant, or
revertant that were able to survive intracellularly at time-
points from 2 to 16 hours post-invasion were not signifi-
cantly different (data not shown).
81–176cj0596 is defective in mouse colonization
To determine whether Cj0596 plays a role in mouse colo-
nization, we used a BALB/c model that has been used pre-
viously to assess colonization differences between wild-
type and mutant bacteria [34,57,67]. Female BALB/c-ByJ
mice were given doses of C. jejuni 81–176, 81–176cj0596,
and 81–176cj0596+ individually (1 × 109 CFU each), as
well as a mixture of wild-type and cj0596 mutant (5 × 108
CFU each) in a competition experiment, and colonization
was measured by determining viable counts of bacteria in
fecal pellets at weekly intervals (Figure 8).
On days 7 and 14, viable bacteria were found in all seven
mice receiving the wild-type, mutant, or the revertant (Fig-
ure 8A). Following the peak in colonization at 14 days,
viable mutant bacteria were recovered from only four
mice on day 21, and only three mice on days 28 and 35.
At these latter three timepoints, the wild-type and rever-
tant were recovered from all but one mouse. The mean
colonization densities of the wild-type and revertant were
1.0 × 106 and 8.4 × 107 CFU/g, respectively, on day 7 and
remained relatively consistent throughout the experi-
ment. The mean colonization level of the mutant was sig-
nificantly lower than wild-type and revertant on days 21
(1.51 × 105 CFU/g; p < 0.05) and 28 (3.42 × 106CFU/g; p
< 0.05). When placed in competition with the wild-type,
the mutant showed an inability to compete for coloniza-
tion (Figure 8B). Wild-type bacteria were recovered from
five mice on day 7, four mice on day 14, and then one
mouse for the remainder of the experiment. Viable
mutant bacteria were recovered from no mice on day 7 (p
< 0.001), two mice on day 14 (p < 0.05; the peak in colo-
nization, as observed in mice given the mutant alone),
one mouse on day 21, and then were not recovered on
days 28 and 35.
Deletion of cj0596 alters C. jejuni protein expression
Because Cj0596 is thought to be a periplasmic chaperone,
its loss could result in compensatory changes in the
expression of other proteins. To determine the effect that
deletion of Cj0596 had on the expression of other pro-
teins, a comparison of total cell proteins from C. jejuni
81–176, 81–176cj0596, and 81–176cj0596+  was per-
formed using 2D SDS-PAGE (Figure 9). Three proteins
were found to be significantly upregulated in the mutant.
They were identified as HtrA (2.5-fold), Cj0998 (2.1-
fold), and FlaA (2.0-fold). As expected, the CAT protein
was found only in the Cj0596 mutant. Conversely, the
Cj0596 protein was found in wild-type and revertant
strains, but was absent in the cj0596 mutant, as expected.
Three proteins were found to be significantly downregu-
lated in the mutant. These proteins were EF-Ts (2.9-fold),
superoxide dismutase (SOD) (2.6-fold), and EF-Tu (two
spots; 2.0-fold, 1.9-fold). All of the proteins that showed
altered abundance in the mutant returned to near wild-
type levels in the revertant.
Discussion
C. jejuni is a major cause of human diarrheal infection
worldwide, yet we have only limited knowledge regarding
Motility of C. jejuni strains at 37°C Figure 6
Motility of C. jejuni strains at 37°C. MH motility plates 
(0.4% agar) were inoculated with strains 81–176 (black), 81–
176cj0596 (red) and 81–176cj0596+ (blue) and the zones of 
motility were measured after 48 hours. Statistical significance 
(p < 0.05) is represented by an asterisk.BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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the mechanisms the bacterium uses to colonize humans
and cause disease. Because C. jejuni inhabits two hosts
with differing body temperatures, we became interested in
proteins (including Cj0596) that are more abundant
when C. jejuni is grown at 37°C (human body tempera-
ture) compared to 42°C (chicken body temperature).
Because of its homology to other PPIases that are involved
in the virulence of other bacteria and the fact that it is
highly conserved among Campylobacter species, this pro-
tein may play an important role in human colonization.
In silico analyses of the gene and protein sequences suggest
that Cj0596 is probably a periplasmic PPIase that is
involved in folding integral outer membrane proteins.
Among the changes that occur in bacterial cells when
encountering lower growth temperatures are a decrease in
membrane fluidity, and inefficient folding of some pro-
teins [68]. Proper protein folding or refolding of cold-
damaged proteins is important after cold shock, and cer-
tain chaperones may be upregulated during cold shock in
an attempt to compensate for the decreased efficiency of
protein folding [69]. In E. coli, several molecular chaper-
ones (including GroEL, GroES, htpG, ppiA, and trigger fac-
tor) were transiently induced upon cold shock [69,70].
Additionally, the chaperone ClpB may renature and solu-
bilize aggregated proteins at low temperatures at which
translation is repressed [71]. Whether the modest induc-
tion of Cj0596 that seems to occur at 37°C has any bio-
logical relevance to protein folding in the periplasm or
modulation of membrane fluidity is a topic for future
study.
Cj0596 is similar to the E. coli protein SurA, which is a
peptidyl prolyl cis-trans  isomerase located in the peri-
plasm and which plays a role in folding outer membrane
proteins, particularly LamB and OmpA, and in pilus bio-
genesis [72-74]. A UPEC strain in which SurA was inacti-
vated was less able to bind and invade bladder epithelial
cells, in addition to showing a decreased ability to survive
intracellularly [75].
There are several other examples of PPIases, and SurA
orthologs in particular, having roles in bacterial patho-
genesis. In S. flexneri, SurA is required for proper folding
and insertion into the outer membrane of IcsA, which is
responsible for the ability of the bacterium to spread inter-
cellularly [28]. Deletion of SurA decreases the ability of S.
enterica to adhere to and invade Caco-2 and RAW264.7
cells in vitro, as well as reducing the capacity to colonize
BALB/c mice [24]. A L. pneumophila mutant lacking the
PPIase Mip was defective in initiating macrophage infec-
tion  in vitro, and less virulent when introduced into a
Abilities of C. jejuni strains to adhere to and invade INT407 cells Figure 7
Abilities of C. jejuni strains to adhere to and invade INT407 cells. Strains 81–176 (black), 81–176cj0596 (red) and 81–
176cj0596+ (blue) were grown to mid-log phase in biphasic culture. INT407 monolayers were inoculated with bacteria at an 
MOI of ~40. After 3 h, the cells were washed and bacteria adhered were enumerated (A). Gentamicin was added to another 
plate of cells and incubation was continued for an additional 2 h after which the cells were washed and bacteria invaded were 
enumerated (B). Statistical significance (p < 0.001) is represented by two asterisks.BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
Page 12 of 16
(page number not for citation purposes)
guinea pig model [23]. Similarly, the C. trachomatis Mip-
like protein and the T. cruzi TcMip protein play roles in
the early steps of intracellular infection by these bacteria
[26,27]. Ng-MIP, found in N. gonorrhoeae, is similar to
these Mips, but plays a role in intracellular survival rather
than invasion [25].
Previously, a C. jejuni NCTC 11168 cj0596 mutant was
found to have a decreased growth rate when growth was
measured by OD600 [29]. Our measurements by OD600
initially suggested that the mutant had a reduced growth
rate, but when growth was monitored using viable counts,
the mutant was found to grow initially at a rate more sim-
ilar to the wild-type, although a modest growth defect was
still apparent at later stages of growth (Figure 5). The dif-
ference in the results obtained by OD600 and viable counts
might be the result of a change in cell size or the light scat-
tering properties of the cj0596 mutant, possibly caused by
a change in the composition of the outer membrane of the
bacterium. Future work, such as using electron micros-
copy to evaluate the shape and surface components of the
mutant, might help explain the reason for the discrepancy
between the results obtained by OD600 measurements and
viable counts.
C. jejuni has two polar flagella which play a major role in
virulence. Flagella-mediated motility is responsible for
colonization of the mucous lining of the mammalian and
avian gastrointestinal tracts as well as invasion of gastroin-
testinal epithelial cells [55,76-78]. We found that the
Colonization of BALB/c-ByJ mice by C. jejuni strains Figure 8
Colonization of BALB/c-ByJ mice by C. jejuni strains. The abilities of strains 81–176 (black circles), 81–176cj0596 (red 
squares), 81–176cj0596+ (blue triangles) to colonize BALB/c-ByJ mice alone (A) and in competition (81–176 [black circles], 81–
176cj0596 [red squares]) (B) were measured. Mice were fed 1 × 109 CFU of each strain, or a mixture of 81–176 and 81–
176cj0596 (5 × 108 CFU each) by oral gavage. Colonization levels were measured by enumeration of bacteria present in fecal 
pellets on days 7, 14, 21, 28, and 35 post-inoculation.BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
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cj0596 mutant was significantly more motile than wild-
type bacteria. Because we found that removal of Cj0596
increased the motility of the bacterium, we considered
that the cj0596 mutant might be more invasive than wild-
type. Studies using INT407 cells showed that mutation of
cj0596 did in fact increase the invasiveness of C. jejuni
without altering the adherence and intracellular survival
abilities. Previously, it was noted that a C. jejuni NCTC
11168  cj0596  mutant was significantly deficient in its
ability to adhere to host cells [29]. The discrepancy in
adherence results seen between the previous study and
our current work could be due to strain differences, how-
ever, we cannot exclude the possibility that the previously
obtained adherence phenotype was due to an unlinked
mutation in the uncomplemented NCTC 11168 cj0596
mutant. The increased motility and invasiveness could be
due to an increase in chemotaxis, or to increased flagellar
function because of a change in outer membrane architec-
ture or cell morphology that provides a motility advan-
tage.
Several proteins located on the cell surface play a role in
the initial cell-to-cell contact that is a component of intes-
tinal colonization by C. jejuni. Because Cj0596 is thought
to be involved in folding outer membrane proteins, its
mutation is likely to have an effect on surface-exposed
proteins, which could affect the ability to colonize the
host intestinal tract. When mice were inoculated individ-
ually with the wild-type, mutant, or revertant, the cj0596
mutant initially was able to colonize at mean levels com-
parable to the wild-type and revertant strains. However,
the mutant became increasingly colonization deficient
over time. The differences were statistically significant at
days 21 and 28, but not at day 35 due to increased clear-
ance of the wild-type and revertant strains from some
mice. This colonization defect is likely not the result of the
increased motility of the mutant, since motility typically
correlates with better animal colonization. One possible
explanation for the decreased colonization ability of the
mutant is that Cj0596 is required for the proper presenta-
tion of surface structures that are necessary for mouse col-
onization (e.g., known or unknown adhesins, oxidative
stress, or other mouse colonization factors). Additionally,
when the mutant was placed in direct competition with
the wild-type, it demonstrated an inability to compete
with the wild-type for colonization of the mice. In compe-
tition experiments, curiously, colonization levels of both
the wild-type and mutant were significantly lower (com-
pared to individual infections), suggesting some sort of
interference of these strains with each other. The cj0596
mutant shows elevated autoaggregation and biofilm for-
mation (manuscript submitted), so it is possible that
these or other features impacting C. jejuni community
structure could be involved.
In an effort to determine some of the molecular causes of
the altered virulence phenotypes discussed previously, we
conducted a proteomic analysis comparing the whole-cell
protein profiles of wild-type, mutant, and revertant. As
expected, CAT was found only in the mutant and Cj0596
was absent in the mutant, confirming the replacement of
cj0596 with the cat cassette in the mutant, and restoration
of Cj0596 expression in the revertant.
A total of six other proteins showed altered expression in
the cj0596 mutant. All proteins that showed altered abun-
Differences in protein expression in C. jejuni strains Figure 9
Differences in protein expression in C. jejuni strains. 2-D SDS-PAGE gels (12%) showing: wild-type (A), cj0596 mutant 
(B), and cj0596 revertant (C) protein profiles. Proteins with greater expression in cj0596 mutant (fold change): HtrA (+2.5), 
Cj0998 (+2.1), FlaA (+2.0). Proteins with lesser expression in cj0596 mutant (fold change): EF-Ts (-2.9), SOD (-2.6), EF-Tu (-
2.0, -1.9). CAT was found only in the cj0596 mutant, and Cj0596 was absent in the mutant. Each of these protein expression 
differences returned to a level statistically similar to wild-type in the revertant.BMC Microbiology 2009, 9:160 http://www.biomedcentral.com/1471-2180/9/160
Page 14 of 16
(page number not for citation purposes)
dance in the mutant returned to near wild-type levels in
the revertant. Three proteins were found to be signifi-
cantly upregulated in the mutant. They were identified as
HtrA (2.5-fold), Cj0998 (2.1-fold), and FlaA (2.0-fold).
HtrA is a serine protease with homologs found in most
bacteria. In E. coli, HtrA is located on the periplasmic side
of the inner membrane [79,80], has protease activity [81],
and has some chaperone activity at low temperatures [82].
It is possible that C. jejuni HtrA is upregulated in the
mutant in a compensatory manner due to an increase in
unfolded protein in the periplasm resulting from the loss
of a major periplasmic PPIase. Brondsted et al. [83] found
that a C. jejuni HtrA mutant showed no change in motility
or autoagglutination, but did have a decreased ability to
adhere to and invade INT407 cells and also exhibited
altered cell morphology. Cj0998 is annotated as 'putative
periplasmic protein' and is restricted primarily to the epsi-
lon proteobacteria, although the function of this protein
is currently unknown. FlaA is the major subunit of the C.
jejuni flagellum, and the upregulation of FlaA is consistent
with the increase in motility and invasion of INT407 cells
seen in the cj0596 mutant.
Three proteins were shown to be significantly downregu-
lated in the cj0596 mutant. They were identified as EF-Ts
(2.9-fold), SOD (2.6-fold), and EF-Tu (two spots; 2.0-
fold, 1.9-fold). Among proteins whose expression was
lower in the cj0596 mutant, EF-Ts and EF-Tu are involved
in protein translation. They may be downregulated in the
mutant due to an increase in unfolded protein in the peri-
plasm and this in turn may result in the late stage growth
defect due to a general decrease in protein synthesis. As C.
jejuni lacks a sigma-E response [22], the signalling mecha-
nism that would be responsible is unknown. SOD plays a
role in protecting C. jejuni against damage from oxidative
stress and mutation of sod in C. coli was found to decrease
the ability of the bacterium to colonize the intestines of 1-
day-old chicks [84]. The decreased levels of SOD in the
cj0596 mutant may therefore play a role in the coloniza-
tion defects seen in mice.
Conclusion
Cj0596 is a highly conserved protein whose expression in
C. jejuni is induced at human body temperature. Bacteria
lacking Cj0596 were found to exhibit changes in several
virulence-related phenotypes, including motility and host
cell invasion, as well as alterations in protein expression
and a defect in mouse colonization.
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